CD8a-168Er | Fluidigm 3168003B product information

product summary

company name :

Fluidigm

product type :

antibody

product name :

CD8a-168Er

catalog :

3168003B

clonality :

monoclonal

conjugate :

nonconjugated

clone name :

53-6.7

The same clone is also sold as:

Santa Cruz Biotechnology: sc-18913, sc-18913 L
Exbio: 1A-579-C100, A4-579-C100, A4-579-C025, 1A-579-C025, 1P-579-C100, PB-579-C025, 1F-579-C100, 12-579-C100, PB-579-C100, 11-579-C100, 11-579-C025
Abcam: Ab25478
BioLegend: 100732, 100776, 100753, 100727, 100749, 100725, 100708, 100789, 100748, 100790, 100779, 100721, 100791, 100783, 100726, 100747, 100746, 100750, 100781, 100771, 100761, 100742, 100766, 100777, 100702, 100707, 100731, 100722, 100780, 100738, 100711, 100762, 100713, 100767, 100798, 100703, 100763, 100701, 100796, 100737, 100712, 100782, 100743, 100770, 100793, 100758, 100752, 100704, 100744, 100769, 100788, 100773, 100729, 100792, 100741, 100710, 100714, 100739, 100734, 100723, 100706, 100751, 100759, 100794, 100772, 100730, 100705, 100797, 100795, 100755, 100765, 100768, 100764, 100709, 100728, 100785, 100724, 100775, 100733, 100740, 100787
OriGene: AM08023PU-N, AM08023RC7-N, AM08023RT-N, AM08023FC-S, AM08023RP-N, AM08023LE-N, AM08023RP-S, AM08023BT-N, AM08023FC-N, AM08023AC7-N
Rockland Immunochemicals: 200-508-N77, 200-526-N77, 200-502-N77
Bio X Cell: BE0004-1-100MG, BE0004-1-5MG, BP0004-1-50MG, BP0004-1-5MG, BP0004-1-25MG, BE0004-1-50MG, BP0004-1-100MG, BE0004-1-25MG, BE0004-1-1MG
Bio-Rad: MCA2694T, MCA2694F, MCA2694, MCA2694PE
Boster: M02236
Miltenyi Biotec: 130-102-807, 130-122-953, 130-120-748, 130-118-147, 130-120-817, 130-120-825, 130-118-329, 130-120-756, 130-102-805, 130-123-280, 130-123-865, 130-102-595, 130-102-409, 130-118-468, 130-118-074, 130-120-159
Novus Biologicals: NBP1-49045, NBP2-80658
ichorbio: ICH1044, ICH1044UL
Abnova: MAB6108, MAB6106, MAB5605, MAB6111, MAB6110, MAB12215, MAB6105, MAB6109, MAB6113, MAB6112, MAB5130, MAB6114, MAB6107
Invitrogen: 45-0081-82, MA1-10304, M003T02Y02, 53-0081-80, A15385, MA5-18153, 17-0081-81, MA1-10303, 15-0081-82, 606-0081-82, 53-0081-82, M003T02Y05, 58-0081-80, 50-0081-82, 47-0081-80, 11-0081-86, M003T02Y01, 16-0081-050, M003T02B08, 606-0081-80, M003T02R01, 12-0081-81, 45-0081-80, 14-0081-86, 367-0081-80, 368-0081-82, 12-0081-85, 16-0081-85, 11-0081-82, M003T02B06, 78-0081-82, 56-0081-82, 62-0081-80, 17-0081-82, 12-0081-83, 368-0081-80, 16-0081-82, 62-0081-82, 505-0081-82, 13-0081-82, 35-0081-80, M003T02R04, M003T02R03, 61-0081-80, 17-0081-83, MA1-10301, 35-0081-82, M003T02Y03, MA1-10302, 15-0081-83, 46-0081-82, 48-0081-82, 48-0081-80, 50-0081-80, 47-0081-82, M003T02B04, 64-0081-82, 63-0081-80, 13-0081-81, 16-0081-025, 61-0081-82, 14-0081-82, 56-0081-80, M003T02B01, 16-0081-38, 46-0081-80, M003T02Y07, 36-0081-85, 505-0081-80, 25-0081-82, 14-0081-85, A15386, M003T02B03, M003T02Y06, 67-0081-82, MA1-84018, 367-0081-82, 16-0081-86, M003T02B07, 11-0081-85, 42-0081-82, 16-0081-81, M003T02R02, 12-0081-82, M003T02Y04, 25-0081-81, 64-0081-80, 11-0081-81, 15-0081-81, M003T02B05, 63-0081-82, 69-0081-82, 13-0081-86, 78-0081-80, M003T02B02, 13-0081-85
Tonbo Biosciences: 65-0081, 30-0081, 70-0081
BD Biosciences: 553035, 563786, 560247, 553033, 561095, 563898, 550281, 560776, 564422, 558733, 557668, 561109, 563332, 562315, 561093, 553029, 558106, 563234, 561967, 563046, 564459, 561966, 560182, 557654, 560471, 562283, 560778, 553034, 552877, 561097, 557959, 560469, 561092, 553028, 563068, 553032, 551162, 561094, 553036, 553030, 553026, 553027, 553031, 557682
R&D Systems: FAB116N-100UG, FAB116T-100UG, FAB116V-100UG, FAB116S-100UG, FAB116G-100, FAB116U-100UG, FAB116R-100UG, FAB116P-100, FAB116F-100, FAB116A-100, MAB116-100, BAM116

reactivity :

mouse

application :

flow cytometry, other, mass cytometry

more info or order :

Fluidigm product webpage

citations: 8

Published Application/Species/Sample/Dilution	Reference
other; mouse; loading ...	Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
mass cytometry; mouse; loading ...; fig s1c	Félix I, Jokela H, Karhula J, Kotaja N, Savontaus E, Salmi M, et al. Single-Cell Proteomics Reveals the Defined Heterogeneity of Resident Macrophages in White Adipose Tissue. Front Immunol. 2021;12:719979 pubmed publisher
mass cytometry; mouse; 1:200; fig 4c	Kemp S, Carpenter E, Steele N, Donahue K, Nwosu Z, Pacheco A, et al. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Cancer Res. 2021;81:4305-4318 pubmed publisher
mass cytometry; mouse; loading ...; fig s3	Lagnado A, Leslie J, Ruchaud Sparagano M, Victorelli S, Hirsova P, Ogrodnik M, et al. Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent manner. EMBO J. 2021;40:e106048 pubmed publisher
mass cytometry; mouse; loading ...; fig 5d	Martinez L, Garcia G, Contreras D, Gong D, Sun R, Arumugaswami V. Zika Virus Mucosal Infection Provides Protective Immunity. J Virol. 2020;94: pubmed publisher
flow cytometry; mouse; 1:100; loading ...; fig 4c, 4d	Parisi G, Saco J, Salazar F, Tsoi J, Krystofinski P, Puig Saus C, et al. Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist. Nat Commun. 2020;11:660 pubmed publisher
mass cytometry; mouse; loading ...; fig 3b, s3a	Tu M, Lee F, Jones R, Kimball A, Saravia E, Graziano R, et al. Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. Sci Adv. 2019;5:eaav2437 pubmed publisher
mass cytometry; mouse; loading ...; fig 5s2b	Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher